These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8524489)

  • 1. Calcium channel blockers and renal dysfunction in arterial hypertension.
    Díez J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():22-6. PubMed ID: 8524489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers: effects on progressive renal disease.
    Zucchelli P; Zuccalà A; Gaggi R
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):94-7. PubMed ID: 2024684
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.
    Marín R; Gorostidi M; Fernández-Vega F; Alvarez-Navascués R
    Kidney Int Suppl; 2005 Dec; (99):S52-6. PubMed ID: 16336577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protecting the kidney in hypertension.
    Weinberg MS; Cottiero RA; Yoburn DC
    R I Med; 1993 May; 76(5):225-8. PubMed ID: 8518496
    [No Abstract]   [Full Text] [Related]  

  • 5. Do calcium antagonists protect the human hypertensive kidney?
    Bauer JH; Reams GP
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):173S-178S. PubMed ID: 2665788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension with co-existing renal disease.
    Bauer JH; Reams GP
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():27-34. PubMed ID: 2090835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.
    Wilson J; Wahbha MM; Martin PG; Hainsworth R; Brownjohn AM; Turney JH; Davies JA; Prentice CR
    Eur J Clin Pharmacol; 1989; 37(5):437-41. PubMed ID: 2689184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers: do they offer renal protection?
    Reams GP
    J Hum Hypertens; 1993 Jun; 7(3):211-9. PubMed ID: 8345486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine calcium channel blockers and renal disease.
    Robles NR; Fici F; Grassi G
    Hypertens Res; 2017 Jan; 40(1):21-28. PubMed ID: 27412800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium antagonists on glomerular hemodynamics and structure in experimental hypertension.
    Dworkin LD
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):89-93. PubMed ID: 2024683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of calcium blockade by tiapamil in normal and hypertensive subjects.
    Ribstein J; Cristol JP; Elkik F; Mimran A
    J Hypertens Suppl; 1985 Dec; 3(3):S165-7. PubMed ID: 2856696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple effects of calcium entry blockers on renal function in hypertension.
    Romero JC; Raij L; Granger JP; Ruilope LM; Rodicio JL
    Hypertension; 1987 Aug; 10(2):140-51. PubMed ID: 3301663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal vascular effects of calcium channel blockers in hypertension.
    Benstein JA; Dworkin LD
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):305S-312S. PubMed ID: 2078317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal protection with calcium antagonism in essential hypertension.
    Bauer JH; Reams GP
    Clin Invest Med; 1989 Oct; 12(5):300-4. PubMed ID: 2689026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension, nephrosclerosis and calcium antagonists].
    del Río A
    Med Clin (Barc); 1989 Jan; 92(3):98-101. PubMed ID: 2709903
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.